<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>thiadiazole β-carboline derivatives &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/thiadiazole-%ce%b2-carboline-derivatives/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 06 Oct 2025 00:53:23 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>thiadiazole β-carboline derivatives &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Designing Thiadiazole β-Carboline Derivatives as Glucosidase Inhibitors</title>
		<link>https://bioengineer.org/designing-thiadiazole-%ce%b2-carboline-derivatives-as-glucosidase-inhibitors/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 06 Oct 2025 00:53:20 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[bioactivity evaluation in enzyme inhibition]]></category>
		<category><![CDATA[diabetes therapeutic agents]]></category>
		<category><![CDATA[medicinal chemistry drug design]]></category>
		<category><![CDATA[thiadiazole β-carboline derivatives]]></category>
		<category><![CDATA[α-glucosidase inhibitors]]></category>
		<guid isPermaLink="false">https://bioengineer.org/designing-thiadiazole-%ce%b2-carboline-derivatives-as-glucosidase-inhibitors/</guid>

					<description><![CDATA[In a significant leap forward in the field of medicinal chemistry, a groundbreaking study has emerged that investigates the potential of thiadiazole-based β-carboline derivatives as inhibitors of α-glucosidase. Conducted by researchers Zhou, Wen, Wang, and associates, this study promises to redefine therapeutic strategies aimed at combating diabetes and related metabolic disorders. The primary focus of [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">276115</post-id>	</item>
	</channel>
</rss>
